Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[HER2-positive breast cancer: standard and double targeted therapy].
Semiglazov VF, Bozhok AA, Semiglazova TIu, Vasil'ev AG, Manikhas AG, Semiglazov VV, Bessonov AA, Nikolaev KS. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2013;59(3):341-6. Vopr Onkol. 2013. PMID: 23909035 Clinical Trial. Russian.
[Phase II clinical trial of neoadjuvant hormone therapy in comparison with chemotherapy of patients with breast cancer].
Semiglazov VF, Semiglazov VV, Dashian GA, Zhil'tsova EK, Ivanov VG, Bozhok AA, Tonuzov EE, Paltuev RM, Mel'nikova OA, Klettsel' AA, Krivorot'ko PV, Donskikh RV, Kochetova IA, Damenia AO, Zernov KIu, Voskresenskiĭ DA, Bershteĭn LM. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2007;53(4):400-8. Vopr Onkol. 2007. PMID: 17969401 Clinical Trial. Russian.
[BREAST-CONSERVING SURGERY AFTER NEOADJUVANT THERAPY FOR BREAST CANCER].
Semiglazov VF, Semiglazov VV, Petrenko OL, Komyakhov AV, Dashyan GA, Paltuev RM, Semiglazova TY, Manikhas AG, Bozhok AA, Lalak IA. Semiglazov VF, et al. Among authors: semiglazov vv. Vopr Onkol. 2015;61(3):381-6. Vopr Onkol. 2015. PMID: 26242149 Clinical Trial. Russian.
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V, Eiermann W, Zambetti M, Manikhas A, Bozhok A, Lluch A, Tjulandin S, Sabadell MD, Caballero A, Valagussa P, Baselga J, Gianni L. Semiglazov V, et al. Eur J Surg Oncol. 2011 Oct;37(10):856-63. doi: 10.1016/j.ejso.2011.07.003. Epub 2011 Aug 16. Eur J Surg Oncol. 2011. PMID: 21843921 Clinical Trial.
[The adjuvant hormonal therapy of breast cancer].
Semiglazov VF, Ivanov VG, Moiseenko VM, Bershteĭn LM, Ivanova OA, Tsyrlina EV, Barash NIu, Bozhok AA. Semiglazov VF, et al. Vopr Onkol. 1995;41(2):126. Vopr Onkol. 1995. PMID: 7483408 Russian. No abstract available.
[Breast-preserving (conservative) therapy of breast cancer].
Semiglazov VF, Kanaev SV, Chagunava OL, Ivanova OA, Pozharisskiĭ KM, Chepik OF, Vesnin AG, Zaĭtsev AN, Orlov AA, Krinitsina NN, Barash NI, Seleznev IK, Migmanova NS, Popova RT, Ivanov VG, Golubeva OM, Bozhok AA. Semiglazov VF, et al. Vopr Onkol. 1996;42(3):26-9. Vopr Onkol. 1996. PMID: 8801736 Review. Russian.
248 results